BIO Google+ Hangouts
Intersection of Academic and Industry
The topics discussed will be:
- Novel collaborations between industry and academia that are driving the commercialization of the next generation of biomedical cures.
- Emerging trends and new models in technology transfer and translational research designed to help university inventions cross the 'valley of death'.
- How BIO's 1-on-1 Partnering and technology transfer programming at BIO 2014 plays a pivotal role in advancing industry-university relationships
- Moderator: Mark Crowell, Executive Director of U.Va. Innovation,
University of Virginia (BIO Tech Transfer Committee Chairman)
- Melissa Fitzgerald, Head, Strategic Research
Partnerships-San Diego at Pfizer
- Lou Berneman, Partner, Osage University Partners and Fund
Advisor, HealthCare Royalty Partners
- Kanad Das, Program Manager at SPARK, Stanford University
- Mari Serebrov, Sr. Editor Washington DC, BioWorld
- Innovation's true "value proposition" and the ways in which investing in science has multilayered societal returns.
- The biggest issues in biotech that continue to "flatten" the world and create common missions among countries.
- The ever-changing landscape of international innovation and the ways government and industry can best support life science development.
Learn how these discussions and data points surrounding them can elucidate unique perspectives on places as diverse as Brazil, Russia, India, China, Africa, Turkey, Latin America and other regions represented at #BIO2014
Guest Speakers Included:
- David Brancaccio, Host of American Public Media’s Marketplace Morning Report. He will also serve as moderator of two plenary sessions at June event.
- Yali Friedman, Lead Editorial Consultant & Scorecard Editor, Scientific American WorldView
- Mike May, Editorial Director, Scientific American WorldView, Moderator, Scientific American WorldView Super Session
- Caroline Ruggieri, Founder & Managing Director, Access Life Sciences